Preliminary report: effects of interleukin-1 on platelet counts

The Lancet

Volumn 336, Issue 8717, 1990, Pages 712-714

  Tewari, A ^a   Starnes Jr , H F ^a   Buhles Jr , W C ^b  

^a STANFORD UNIVERSITY   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 1BETA;

ARTICLE; CLINICAL ARTICLE; FEMALE; FEVER; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; RIGOR; SIDE EFFECT; THROMBOCYTOPENIA;

ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HEMATOPOIESIS; HUMAN; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1; INTERLEUKIN-3; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGE; NEOPLASMS; NEUTROPHILS; PLATELET COUNT; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0025108171     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)92206-W     Document Type: Article

References (26)

1. Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes
2. Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophpage-CSF following stimulation by interleukin-1 and poly (rI).poly (rC)
3. Interleukin-1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells
4. Interleukin-1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor
5. Interleukin-1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage-colony-stimulating factor
6. Interleukin-3 and interleukin-1β allow earlier bone marrow progenitors to respond to human colony-stimulating factor I
7. In vivo hematopoietic effects of recombinant interleukin-1α in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin
8. Regulation of hematopoiesis in myelosuppressed mice by recombinant IL-1&agr
9. The role of interleukin-6 and interleukin-1 in megakaryocyte development
10. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
11. Human interleukin-1: purification to homogeneity
12. Platelet counts with the Coulter counter.
13. Establishment of growth factor-dependent MOPC 104E cell line in vitro
14. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation
15. Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer
16. Alterations in megakaryocyte and platelet compartments following in vivo IL-1β administration to normal mice
17. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor
18. Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony stimulating factor
19. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression
20. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy
21. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease
22. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia
23. Effect of recombinant human interleukin-3 (rhIL-3) in patients with bone marrow failure—a phase I/II trial
24. Interleukin-6 is a potent thrombopoietic factor in vivo in mice
25. Stimulation of thrombopoiesis in mice by human recombinant interleukin-6
26. Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts